NCT00156091 Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784) Status COMPLETED Phase PHASE3
NCT00151424 Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947) Status COMPLETED Phase PHASE3
NCT00150215 A First In Human Study Of PF-00184562 In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00149292 Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo Status COMPLETED Phase PHASE2
NCT00148564 Energy Homeostasis Under Treatment With Atypical Antipsychotics Status COMPLETED Phase PHASE4
NCT00145496 Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771) Status COMPLETED Phase PHASE3
NCT00145444 Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study Status COMPLETED Phase PHASE3
NCT00143182 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00129220 Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00124930 Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer Status TERMINATED Phase PHASE3
NCT00113594 Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00103571 Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00100776 Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder Status COMPLETED Phase PHASE4
NCT00094549 Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder Status COMPLETED Phase PHASE4
NCT00091650 Olanzapine in Patients With Borderline Personality Disorder Status COMPLETED Phase PHASE3
NCT00090012 Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder Status COMPLETED Phase PHASE4
NCT00089869 A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT00088049 Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia Status COMPLETED Phase PHASE4
NCT00088036 Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder Status COMPLETED Phase PHASE3